|
|
|
|
LEADER |
04578nam a2200421 4500 |
001 |
ocn785225436 |
003 |
OCoLC |
005 |
20180501121956.0 |
006 |
m o d |
007 |
cr mn||||a|||| |
008 |
120410s2012 cauaf ob 001 0 eng d |
040 |
|
|
|a MKC
|b eng
|e pn
|c MKC
|d MBB
|d CDX
|d OCLCQ
|d CUS
|d OPELS
|d OCLCF
|d VVL
|d KUK
|d MERUC
|d OCLCQ
|d CASUM
|d OCLCO
|d NJR
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d KIJ
|d OCLCO
|d OCLCQ
|d GrThAP
|
019 |
|
|
|a 794822372
|
020 |
|
|
|a 9780123918604
|q (electronic bk.)
|
020 |
|
|
|a 012391860X
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)785225436
|z (OCoLC)794822372
|
050 |
|
4 |
|a R857.N34
|
060 |
0 |
0 |
|a W1
|b ME9615K no.508 2012
|
060 |
1 |
0 |
|a QT 25
|
082 |
0 |
4 |
|a 610.2/8
|2 23
|
049 |
|
|
|a TEFA
|
245 |
0 |
0 |
|a Nanomedicine :
|b cancer, diabetes, and cardiovascular, central nervous system, pulmonary and inflammatory diseases /
|c volume editor, Nejat Düzgüneş.
|
260 |
|
|
|a San Diego :
|b Academic Press/Elsevier,
|c ©2012.
|
300 |
|
|
|a 1 online resource (lii, 434 pages, [16] pages of plates) :
|b illustrations (some color).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in enzymology ;
|v v. 508
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Preparation, characterization, and cellular associations of silicon logic-embedded vectors / Anne L. van de Ven [and others] -- Postformulation peptide drug loading of nanostructures / Hua Pan [and others] -- Application of mesoporous silica nanoparticles in intracellular delivery of molecules and proteins / I-Ju Fang and Brian G. Trewyn -- Multifunctional anticancer nanomedicine based on a magnetically responsive cyanoacrylate polymer / José L. Arias, Visitación Gallardo, and M. Adolfina Ruiz -- Development and use of ceramide nanoliposomes in cancer / Rebecca J. Watters [and others] -- Multistage nanoparticles for improved delivery into tumor tissue / Triantafyllos Stylianopoulos [and others] -- Mitochondria-specific nanocarriers for improving the proapoptotic activity of small molecules / Volkmar Weissig -- Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles / Fabienne Danhier [and others] -- Peptide nanofiber scaffold for brain tissue reconstruction / Gilberto Ka Kit Leung, Yue Chun Wang, and Wutian Wu -- Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles / S. Sibel Erdem [and others] -- Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging / Mark E. Lobatto [and others] -- Lipid nanoparticles for drug targeting to the brain / Maria Luisa Bondì, Roberto Di Gesù, and Emanuela Fabiola Craparo -- Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles / Müge Yemişci [and others] -- Nanotechnology as a promising strategy for alternative routes of insulin delivery / Catarina Pinto Reis and Christiane Damgé -- Chitosan-coated solid lipid nanoparticles for insulin delivery / Pedro Fonte [and others] -- Peptide nanomedicines for treatment of acute lung injury / Ruxana T. Sadikot -- Nanoparticle-mediated treatment of pulmonary arterial hypertension / W. Mosgoeller, R. Prassl, and A. Zimmer -- Nanomedicines for inflammatory diseases / Fatima A. Khaja, Otilia M.Y. Koo, and Hayat Önyüksel -- Polymeric nanoparticles for the selective therapy of inflammatory bowel disease / Philip Wachsmann and Alf Lamprecht.
|
520 |
|
|
|a This volume in the Methods in Enzymology series comprehensively covers Cancer, Cardiovascular and the central nervous system of Nanomedicine. With an international board of authors, this volume is split into sections that cover subjects such as Diabetes and nanotechnology as potential therapy, Nanomedicines for inflammatory diseases, and Development and use of ceramide nanoliposomes in cancer. Comprehensively covers cancer and the cardiovascular and central nervous systems of nanomedicineAn international board of authorsSplit into sections that cover subjects such as diabetes and nanotechnology as potential therapy, nanomedicines for inflammatory diseases, and the development and use of ceramide nanoliposomes in cancer.
|
650 |
|
0 |
|a Nanomedicine.
|
650 |
|
7 |
|a Nanomedicine.
|2 fast
|0 (OCoLC)fst01744350
|
650 |
1 |
2 |
|a Nanomedicine.
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Düzgüneş, Nejat.
|
830 |
|
0 |
|a Methods in enzymology ;
|v v. 508.
|x 1557-7988
|
856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00766879/508
|z Full Text via HEAL-Link
|